Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.

Rinke, Anja; Gress, Thomas M

Rinke, Anja; Gress, Thomas M.

Affiliation

Rinke A; Department of Gastroenterology, University Hospital Marburg, Marburg, Germany.

Digestion ; 95(2): 109-114, 2017.

Article in En | MEDLINE | ID: mdl-28161703

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Neuroendocrine/drug therapy; Carcinoma, Neuroendocrine/pathology; Gastrointestinal Neoplasms/drug therapy; Gastrointestinal Neoplasms/pathology; Neuroendocrine Tumors/drug therapy; Neuroendocrine Tumors/pathology; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Camptothecin/therapeutic use; Carboplatin/administration & dosage; Carboplatin/therapeutic use; Carcinoma, Neuroendocrine/mortality; Cisplatin/administration & dosage; Cisplatin/therapeutic use; Etoposide/administration & dosage; Etoposide/therapeutic use; Gastrointestinal Neoplasms/mortality; Humans; Irinotecan; Ki-67 Antigen/analysis; Neoplasm Grading; Neuroendocrine Tumors/mortality; Practice Guidelines as Topic; Prognosis; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neuroendocrine Tumors / Carcinoma, Neuroendocrine / Gastrointestinal Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Digestion Year: 2017 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google